Affymax, Inc. (AFFY)
-NasdaqGS 1.33 
0.10(6.99%) 18 May 04:00 SGT|After Hours
:
1.40 0.07 (5.26%) 18 May 07:17 SGT
| Prev Close: | 1.43 |
|---|
| Open: | 1.44 |
|---|
| Bid: | 1.35 x 100 |
|---|
| Ask: | 1.43 x 1000 |
|---|
| 1y Target Est: | 0.67 |
|---|
| Beta: | 1.47 |
|---|
| Next Earnings Date: | 6-Aug-13 |
|---|
| Day's Range: | 1.32 - 1.46 |
|---|
| 52wk Range: | 0.78 - 27.74 |
|---|
| Volume: | 6,491,832 |
|---|
| Avg Vol (3m): | 9,492,300 |
|---|
| Market Cap: | 49.86M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -4.12 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Most active Nasdaq-traded stocksAP(Sat, 18 May)
- AFFYMAX INC FinancialsEDGAR Online Financials(Sat, 18 May)
- AFFYMAX INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Change in Directors or Principal OfficeEDGAR Online(Wed, 15 May)
- AFFYMAX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal OfficersEDGAR Online(Tue, 14 May)
- Monday Sector Leaders: Biotechnology, Drugsat Forbes(Tue, 14 May)
- Affymax says may be unable to continue operationstheflyonthewall.com(Fri, 10 May)
- Sales disappoint, but tax gain lifts Amgen profitAP(Wed, 24 Apr)
- Amgen 1Q profit up 21 pct. on lower taxesAP(Wed, 24 Apr)
- Amgen 1Q profit up 21 pct on lower taxes, expensesAP(Wed, 24 Apr)
- Earnings Preview: Amgen reports 1Q results TuesdayAP(Fri, 19 Apr)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.68 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.31 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.29 |
|---|
| Mean Recommendation*: | 3.2 |
|---|
| PEG Ratio (5 yr expected): | -0.16 |
|---|
Business Summary
Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
View More